Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Current Dermatology Reports
Erschienen in: Current Dermatology Reports 3/2017

07.08.2017 | Epidemiology (R Dellavalle, Section Editor)

Global Burden of Skin Disease: Inequities and Innovations

verfasst von: Divya Seth, Khatiya Cheldize, Danielle Brown, Esther E. Freeman

Erschienen in: Current Dermatology Reports | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

We review the current understanding of the burden of dermatological disease through the lens of the Global Burden of Disease project, evaluate the impact of skin disease on quality of life in a global context, explore socioeconomic implications, and finally summarize interventions towards improving quality of dermatologic care in resource-poor settings.

Recent Findings

The Global Burden of Disease project has shown that skin diseases continue to be the 4th leading cause of non-fatal disease burden worldwide. However, research efforts and funding do not match with the relative disability of skin diseases. International and national efforts, such as the WHO List of Essential Medicines, are critical towards reducing the socioeconomic burden of skin diseases and increasing access to care. Recent innovations such as teledermatology, point-of-care diagnostic tools, and task shifting help to provide dermatological care to underserved regions in a cost-effective manner.

Summary

Skin diseases cause significant non-fatal disability worldwide, especially in resource-poor regions. Greater impetus to study the burden of skin disease in low-resource settings and policy efforts towards delivering high-quality care are essential in improving the burden of skin diseases.
Literatur
1.
Freeman EE. A seat at the big table: expanding the role of dermatology at the World Health Organization and beyond. J Invest Dermatol. 2014;134(11):2663–5.CrossRefPubMed
2.
Engelman D, Fuller LC, Solomon AW, McCarthy JS, Hay RJ, Lammie PJ, et al. Opportunities for integrated control of neglected tropical diseases that affect the skin. Trends Parasitol. 2016;32(11):843–54.CrossRefPubMed
3.
Tschachler E, Bergstresser PR, Stingl G. HIV-related skin diseases. Lancet. 1996;348(9028):659–63.CrossRefPubMed
4.
• Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;134(6):1527–34. Epidemiological study based on the 2010 Global Burden of Disease project that measures the burden of skin diseases worldwide, with burden of individual skin diseases measured in DALYs.CrossRefPubMed
5.
6.
•• Karimkhani C, Dellavalle RP, Coffeng LE, Flohr C, Hay RJ, Langan SM, et al. Global skin disease morbidity and mortality: An Update From the Global Burden of Disease Study 2013. JAMA Dermatol [Internet]. 2017 Mar 1. Epidemiological study based on the 2013 Global Burden of Disease project that measures the burden of skin diseases worldwide, with burden of individual skin diseases measured in DALYs.
7.
Boyers LN, Karimkhani C, Naghavi M, Sherwood D, Margolis DJ, Hay RJ, et al. Global mortality from conditions with skin manifestations. J Am Acad Dermatol. 2014;71(6):1137–43.e17.CrossRefPubMed
8.
9.
Jobanputra R, Bachmann M. The effect of skin diseases on quality of life in patients from different social and ethnic groups in Cape Town. South Africa Int J Dermatol. 2000;39(11):826–31.CrossRefPubMed
10.
Basra M, Fenech R, Gatt R, Salek M, Finlay A. The Dermatology Life Quality Index 1994–2007: a comprehensive review of validation data and clinical results. Br J Dermatol. 2008;159(5):997–1035.PubMed
11.
Chren M-M, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol. 1996;107(5):707–13.CrossRefPubMed
12.
Beattie PE, Lewis-Jones MS. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases. Br J Dermatol. 2006;155(1):145–51.CrossRefPubMed
13.
Weisshaar E, Apfelbacher C, Jäger G, Zimmermann E, Bruckner T, Diepgen TL, et al. Pruritus as a leading symptom: clinical characteristics and quality of life in German and Ugandan patients. Br J Dermatol. 2006;155(5):957–64.CrossRefPubMed
14.
Worth C, Heukelbach J, Fengler G, Walter B, Liesenfeld O, Feldmeier H. Impaired quality of life in adults and children with scabies from an impoverished community in Brazil. Int J Dermatol. 2012;51(3):275–82.CrossRefPubMed
15.
McCabe RE, Antony MM, Summerfeldt LJ, Liss A, Swinson RP. Preliminary examination of the relationship between anxiety disorders in adults and self-reported history of teasing or bullying experiences. Cogn Behav Ther. 2003;32(4):187–93.CrossRefPubMed
16.
Mosam A, Vawda NB, Gordhan AH, Nkwanyana N, Aboobaker J. Quality of life issues for South Africans with acne vulgaris. Clin Exp Dermatol. 2005;30(1):6–9.CrossRefPubMed
17.
Hariram P, Mosam A, Aboobaker J, Esterhuizen T. Quality of life in psoriasis patients in KwaZulu Natal, South Africa. Indian J Dermatol Venereol Leprol. 2011;77(3):333–4.CrossRefPubMed
18.
Aghaei S, Moradi A, Ardekani G. Impact of psoriasis on quality of life in Iran. Indian J Dermatol Venereol Leprol. 2009;75(2):220.CrossRefPubMed
19.
Gibbs SAM. Skin disease and socioeconomic conditions in rural Africa: Tanzania. Int J Dermatol. 1996;35(9):633–9.CrossRefPubMed
20.
Harrison LH, Dwyer DM, Maples CT, Billmann L. Risk of meningococcal infection in college students. JAMA. 1999;281(20):1906–10.CrossRefPubMed
21.
Raoult D, Foucault C, Brouqui P. Infections in the homeless. Lancet Infect Dis. 1(2):77–84.
22.
23.
Dror DM, van Putten-Rademaker O, Koren R. Cost of illness: evidence from a study in five resource-poor locations in India. 2008.
24.
Hay RJ, Fuller LC. The assessment of dermatological needs in resource-poor regions. Int J Dermatol. 2011;50(5):552–7.CrossRefPubMed
25.
Laing R, Waning B, Gray A, Ford N, t Hoen E. 25 years of the WHO essential medicines lists: progress and challenges. Lancet. 5;361(9370):1723–9.
26.
Narwane S, Patel T, Shetty Y, Chikhalkar S. Drug utilization and cost analysis for common skin diseases in dermatology OPD of an Indian tertiary care hospital-a prescription survey. 2011.
27.
Molyneux DH, Hotez PJ, Fenwick A. “Rapid-impact interventions”: how a policy of integrated control for Africa’s neglected tropical diseases could benefit the poor. PLoS Med. 2005;2(11):e336.CrossRefPubMedPubMedCentral
28.
Guthmann J-P, Arlt D, Garcia LML, Rosales M, de Jesus SJ, Alvarez E, et al. Control of mucocutaneous leishmaniasis, a neglected disease: results of a control programme in Satipo Province, Peru. Trop Med Int Health. 2005;10(9):856–62.CrossRefPubMed
29.
• Karimkhani C, Boyers LN, Margolis DJ, Naghavi M, Hay RJ, Williams HC, et al. Comparing cutaneous research Funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases with 2010 Global Burden of Disease results. PLOS ONE. 2014;9(7):e102122. Study examines relationship of NIAMS grant funding with relative skin disease burden for 15 skin diseases included in the Global Burden of Disease 2010.CrossRefPubMedPubMedCentral
30.
Karimkhani C, Boyers LN, Prescott L, Welch V, Delamere FM, Nasser M, et al. Global burden of skin disease as reflected in Cochrane Database of Systematic Reviews. JAMA Dermatol. 2014;150(9):945–51.CrossRefPubMed
31.
Paul S, Evans R, Maurer T, Muhe LM, Freeman EE. Treatment of dermatological conditions associated with HIV/AIDS: the scarcity of guidance on a global scale. AIDS Res Treat. 2016;2016:e3272483.
32.
Oxman AD, Lavis JN, Fretheim A. Use of evidence in WHO recommendations. Lancet. 2007;369(9576):1883–9.CrossRefPubMed
33.
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–6.CrossRefPubMedPubMedCentral
34.
Aneja S, Aneja S, Bordeaux JS. Association of increased dermatologist density with lower melanoma mortality. Arch Dermatol. 2012;148(2):174–8.CrossRefPubMed
35.
Wootton R. Telehealth in the developing world. IDRC; 2009. 336 p.
36.
Osei-tutu A, Shih T, Rosen A, Amanquah N, Chowdhury M, Nijhawan RI, et al. Mobile teledermatology in Ghana: sending and answering consults via mobile platform. J Am Acad Dermatol. 2013;69(2):e90–1.CrossRefPubMed
37.
Azfar RS, Lee RA, Castelo-Soccio L, Greenberg MS, Bilker WB, Gelfand JM, et al. Reliability and validity of mobile Teledermatology in human immunodeficiency virus-positive patients in Botswana: a pilot study. JAMA Dermatol. 2014;150(6):601–7.CrossRefPubMedPubMedCentral
38.
Tran K, Ayad M, Weinberg J, Cherng A, Chowdhury M, Monir S, et al. Mobile teledermatology in the developing world: implications of a feasibility study on 30 Egyptian patients with common skin diseases. J Am Acad Dermatol. 2011;64(2):302–9.CrossRefPubMed
39.
Lamel SA, Haldeman KM, Ely H, Kovarik CL, Pak H, Armstrong AW. Application of mobile teledermatology for skin cancer screening. J Am Acad Dermatol. 2012;67(4):576–81.CrossRefPubMed
40.
Armstrong AW, Johnson MA, Lin S, Maverakis E, Fazel N, Liu F-T. Patient-centered, direct-access online care for management of atopic dermatitis: a randomized clinical trial. JAMA Dermatol. 2015;151(2):154–60.CrossRefPubMed
41.
Azfar RS, Weinberg JL, Cavric G, Lee-Keltner IA, Bilker WB, Gelfand JM, et al. HIV-positive patients in Botswana state that mobile teledermatology is an acceptable method for receiving dermatology care. J Telemed Telecare. 2011;17(6):338–40.CrossRefPubMedPubMedCentral
42.
Peeling RW, Mabey D. Point-of-care tests for diagnosing infections in the developing world. Clin Microbiol Infect. 2010;16(8):1062–9.CrossRefPubMed
43.
Mabey D, Peeling RW, Ustianowski A, Perkins MD. Tropical infectious diseases: diagnostics for the developing world. Nat Rev Microbiol. 2004;2(3):231–40.CrossRefPubMed
44.
45.
Yager P, Domingo GJ, Gerdes J. Point-of-care diagnostics for global health. Annu Rev Biomed Eng. 2008;10:107–44.CrossRefPubMed
46.
Pattabhi S, Whittle J, Mohamath R, El-Safi S, Moulton GG, Guderian JA, et al. Design, development and evaluation of rK28-based point-of-care tests for improving rapid diagnosis of visceral leishmaniasis. PLoS Negl Trop Dis. 2010;4(9):e822.CrossRefPubMedPubMedCentral
47.
Amerson E, Woodruff CM, Forrestel A, Wenger M, McCalmont T, LeBoit T, Maurer T. Accuracy of clinical suspicion and pathologic diagnosis of Kaposi Sarcoma in East Africa. J Acquir Immune Defic Syndr. 1999;71(3):295–301. doi: 10.​1097/​QAI.​0000000000000862​.
48.
49.
50.
51.
Sanne I, Orrell C, Fox MP, Conradie F, Ive P, Zeinecker J, et al. Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial. Lancet Lond Engl. 2010;376(9734):33–40.CrossRef
52.
Tsang MW, Kovarik CL. The role of dermatopathology in conjunction with teledermatology in resource-limited settings: lessons from the African Teledermatology Project. Int J Dermatol. 2011;50(2):150–6.CrossRefPubMedPubMedCentral
53.
54.
Fairall L, Bachmann MO, Lombard C, Timmerman V, Uebel K, Zwarenstein M, et al. Task shifting of antiretroviral treatment from doctors to primary-care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster-randomised trial. Lancet. 2012;380(9845):889–98.CrossRefPubMedPubMedCentral
55.
Morris MB, Chapula BT, Chi BH, Mwango A, Chi HF, Mwanza J, et al. Use of task-shifting to rapidly scale-up HIV treatment services: experiences from Lusaka, Zambia. BMC Health Serv Res. 2009;9:5.CrossRefPubMedPubMedCentral
56.
Shumbusho F, van Griensven J, Lowrance D, Turate I, Weaver MA, Price J, et al. Task shifting for scale-up of HIV care: evaluation of nurse-centered antiretroviral treatment at rural health centers in Rwanda. PLoS Med. 2009;6(10):e1000163.CrossRefPubMedPubMedCentral
57.
• Laker-Oketta M, Wenger M, Semeere A, Castelnuovo B, Kambugu A, Lukande R, et al. Task shifting and skin punch for the histologic diagnosis of Kaposi’s sarcoma in Sub-Saharan Africa: a public health solution to a public health problem. Oncology. 2015;89(1):60–5. Study that examined task-shifting biopsies for Kaposi's Sarcoma diagnosis in East Africa from physicians to non-physicians, finding that task-shifting led to significant increase in healthcare access.CrossRefPubMedPubMedCentral
58.
59.
60.
61.
• Scott KW, Jha AK. Putting quality on the global health agenda. N Engl J Med. 2014;371(1):3–5. Perspective that emphasizes that access to high-quality care is an important goal when addressing global health need.CrossRefPubMed
Metadaten
Titel
Global Burden of Skin Disease: Inequities and Innovations
verfasst von
Divya Seth
Khatiya Cheldize
Danielle Brown
Esther E. Freeman
Publikationsdatum
07.08.2017
Verlag
Springer US
Erschienen in
Current Dermatology Reports / Ausgabe 3/2017
Elektronische ISSN: 2162-4933
DOI
https://doi.org/10.1007/s13671-017-0192-7

Weitere Artikel der Ausgabe 3/2017

Current Dermatology Reports 3/2017 Zur Ausgabe

Epidemiology (R Dellavalle, Section Editor)

Phytochemicals and Naturally Occurring Substances in the Chemoprevention of Skin Cancer

Skin Cancer (D Siegel and O Markowitz, Section Editors)

Reflectance Confocal Microscopy for Margin Assessment and Management of Lentigo Maligna

Epidemiology (R Dellavalle, Section Editor)

Environmental Risk Factors for Development of Atopic Dermatitis: a Systematic Review

Epidemiology (R Dellavalle, Section Editor)

Skin Cancer Prevention Among Hispanics: a Review of the Literature

Epidemiology (R Dellavalle, Section Editor)

Recent Advances in Our Understanding of the Epidemiology of Melanoma

Atopic Dermatitis (T.Bieber, Section Editor)

Atopic Dermatitis in Infants and Toddlers: a Diagnostic Challenge in Daily Practice

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

22.04.2024 | DGIM 2024 | Nachrichten

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

16.04.2024 | DGIM 2024 | Nachrichten

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

13.04.2024 | Klinik aktuell | Kongressbericht | Nachrichten

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

12.04.2024 | Vitiligo | Nachrichten

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt
weitere anzeigen

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise